Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria.

Literature DB >> 20047117

Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria.

Ferdinand Ploner¹, Johannes Zacherl, Friedrich Wrba, Friedrich Längle, Evelyne Bareck, Wolfgang Eisterer, Thomas Kühr, Wolfgang Schima, Michael Häfner, Thomas Brodowicz.

Abstract

Adequate treatment of gastrointestinal stromal tumors (GISTs) is linked to an interdisciplinary treatment approach. Austrian representatives of medical oncology, surgery, pathology, radiology and gastroenterology have issued this consensus manuscript within the context of currently available and published literature. The paper contains guidelines and recommendations for diagnosis, therapy and follow-up of GIST patients in Austria.

Entities: Disease Species

Mesh：

Year: 2009 PMID： 20047117 DOI： 10.1007/s00508-009-1278-4

Source DB: PubMed Journal: Wien Klin Wochenschr ISSN： 0043-5325 Impact factor: 1.704

67 in total

1. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.

Authors: Yoshihide Otani; Toshiharu Furukawa; Masashi Yoshida; Yoshiro Saikawa; Norihito Wada; Masakazu Ueda; Tetsuro Kubota; Makio Mukai; Kaori Kameyama; Yoshinori Sugino; Koichiro Kumai; Masaki Kitajima
Journal: Surgery Date: 2006-04 Impact factor: 3.982

Review 2. Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review.

Authors: Fausto Catena; Monica Di Battista; Pietro Fusaroli; Luca Ansaloni; Valerio Di Scioscio; Donatella Santini; Maria Pantaleo; Guido Biasco; Giancarlo Caletti; Antonio Pinna
Journal: J Gastrointest Surg Date: 2007-11-27 Impact factor: 3.452

Review 3. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors: M Miettinen; J Lasota
Journal: Virchows Arch Date: 2001-01 Impact factor: 4.064

4. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Authors: Michael C Heinrich; Robert G Maki; Christopher L Corless; Cristina R Antonescu; Amy Harlow; Diana Griffith; Ajia Town; Arin McKinley; Wen-Bin Ou; Jonathan A Fletcher; Christopher D M Fletcher; Xin Huang; Darrel P Cohen; Charles M Baum; George D Demetri
Journal: J Clin Oncol Date: 2008-10-27 Impact factor: 44.544

5. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.

Authors: W Ruka; P Rutkowski; A Szawłowski; Z Nowecki; M Debiec-Rychter; U Grzesiakowska; W Dziewirski; J A Siedlecki; W Michej
Journal: Eur J Surg Oncol Date: 2008-03-04 Impact factor: 4.424

6. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors: Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal: J Clin Oncol Date: 2008-02-01 Impact factor: 44.544

Review 7. Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy.

Authors: Eva Wardelmann; Reinhard Büttner; Sabine Merkelbach-Bruse; Hans-Ulrich Schildhaus
Journal: Virchows Arch Date: 2007-08-14 Impact factor: 4.064

8. Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

Authors: Jean-Yves Blay; Axel Le Cesne; Isabelle Ray-Coquard; Binh Bui; Florence Duffaud; Catherine Delbaldo; Antoine Adenis; Patrice Viens; Maria Rios; Emmanuelle Bompas; Didier Cupissol; Cecile Guillemet; Pierre Kerbrat; Jérome Fayette; Sylvie Chabaud; Patrice Berthaud; David Perol
Journal: J Clin Oncol Date: 2007-03-20 Impact factor: 44.544

9. Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach.

Authors: V Pitsinis; A Z Khan; I Cranshaw; W H Allum
Journal: Hepatogastroenterology Date: 2007-03

Review 10. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease.

Authors: Peter J Roberts; Burton Eisenberg
Journal: Eur J Cancer Date: 2002-09 Impact factor: 9.162

1 in total

1. [Consensus diagnosis and therapy of soft tissue sarcoma].

Authors: Thomas Brodowicz; Gabriele Amann; Andreas Leithner; Arpad Sztankay; Franz Kainberger; Wolfgang Eisterer; Bernadette Liegl-Atzwanger; Franz Rachbauer; Thomas Rath; Michael Bergmann; Philipp T Funovics; Ferdinand Ploner; Reinhard Windhager
Journal: Wien Klin Wochenschr Date: 2011-10-28 Impact factor: 1.704

1 in total